SCHEMBL9174081

SCHEMBL9174081

O=C(NCc1ccccn1)c1cccc(C(=O)N2Cc3ccccc3Oc3ccc(Cl)cc32)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ MAPT P10636 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ THPO P40225 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ PTGER1 P34995 8/20 0.48
▸ PTGER2 P43116 3/20 0.48
▸ HPGD P15428 2/20 0.45
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ ANO1 Q5XXA6 1/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TSHR P16473 1/20 0.41
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9166799 0.87 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9173418 0.87 PTGER1 (0.58) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9172122 0.87 HPGD (0.52) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9172765 0.85 PTGER1 (0.50) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9169824 0.85 ALDH1A1 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9172155 0.85 HPGD (0.49) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9157050 0.85 MAPT (0.61) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9172644 0.84 PTGER1 (0.50) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL8798741 0.80 SLC40A1 (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1
SCHEMBL9172756 0.79 HPGD (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5420270-A ANALGESICS; FOR TREATMENT OF PROSTAGLANDIN E2 MEDIATED DISEASES G. D. SEARLE & CO. (US) 1995-05-30 — — US claimed
US-5420270-A ANALGESICS; FOR TREATMENT OF PROSTAGLANDIN E2 MEDIATED DISEASES G. D. SEARLE & CO. (US) 1995-05-30 — — US disclosed
Send feedback